» Articles » PMID: 14981172

Early Risk of Recurrence by Subtype of Ischemic Stroke in Population-based Incidence Studies

Overview
Journal Neurology
Specialty Neurology
Date 2004 Feb 26
PMID 14981172
Citations 195
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To study the early risk of recurrent stroke by etiologic subtype.

Methods: The authors studied risk of recurrent stroke by etiologic subtype (Trial of ORG 10172 in Acute Stroke Treatment [TOAST] classification) in patients in two population-based studies: the Oxford Vascular Study and the Oxfordshire Community Stroke Project. A meta-analysis was performed with data from the only two other published studies reporting equivalent data.

Results: The four studies included 1,709 strokes with 30 recurrences at 7 days, 72 at 30 days, and 113 at 3 months. Recurrent stroke risk varied between subtypes (p < 0.001). Compared with other subtypes, patients with stroke due to large-artery atherosclerosis (LAA) had the highest odds of recurrence at 7 days (odds ratio [OR] = 3.3, 95% CI = 1.5 to 7.0), 30 days (OR = 2.9, 95% CI = 1.7 to 4.9), and 3 months (OR = 2.9, 95% CI = 1.9 to 4.5). Odds of recurrence at 30 days for other subtypes were cardioembolic (OR = 1.0, 95% CI = 0.6 to 1.7), undetermined (OR = 1.0, 95% CI = 0.6 to 1.6), and small-vessel stroke (OR = 0.2, 95% CI = 0.1 to 0.6). There was no significant heterogeneity between the studies. Although only 14% of strokes were associated with LAA, this subtype accounted for 37% of recurrences within 7 days.

Conclusions: The risk of early recurrent stroke is highest in patients with LAA. This supports the need for urgent carotid imaging and prompt endarterectomy.

Citing Articles

A multicenter analysis to identify the risk factors for stroke recurrence and mortality within 1 year.

Alraddadi E, Alotaibi H, Alatawi Y, Aljabri A, Alghamdi A, Alturki F Front Neurol. 2025; 16:1478175.

PMID: 40040911 PMC: 11878097. DOI: 10.3389/fneur.2025.1478175.


[Secondary stroke prevention].

Bachhuber A Radiologie (Heidelb). 2025; 65(2):127-130.

PMID: 39808268 DOI: 10.1007/s00117-024-01411-z.


Importance of infarct topography in determination of stroke mechanism and recurrence risk: a post-hoc analysis of the dabigatran acute treatment of stroke trial.

Cimen E, Ng K, Buck B, Field T, Coutts S, Gioia L BMJ Open. 2025; 15(1):e087704.

PMID: 39788764 PMC: 11751999. DOI: 10.1136/bmjopen-2024-087704.


Early antiplatelet therapy after intravenous thrombolysis for acute ischemic stroke: a systematic review and meta-analysis.

Kelani H, Naeem A, Elhalag R, Abuelazm M, Albaramony N, Abdelazeem A Neurol Sci. 2024; 46(2):617-631.

PMID: 39470903 PMC: 11772446. DOI: 10.1007/s10072-024-07821-0.


Incident Infarcts in Patients With Stroke and Cerebral Small Vessel Disease: Frequency and Relation to Clinical Outcomes.

Clancy U, Arteaga-Reyes C, Garcia D, Hewins W, Locherty R, Valdes Hernandez M Neurology. 2024; 103(5):e209750.

PMID: 39159417 PMC: 11361828. DOI: 10.1212/WNL.0000000000209750.